Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PLK1: A Promising Therapeutic Target for Prostate Cancer Treatment.

Serican journal of medicine·2026
Same author

Cordycepin alleviates aluminium chloride-induced neurodevelopmental toxicity in zebrafish embryos by modulating inflammation and Wnt signaling.

Neurochemistry international·2026
Same author

A biomimetic strip for standardized evaluation of herbicide deposition dynamics.

Materials horizons·2026
Same author

Interacting and joint impact of oxidative balance score and insulin resistance on cardiovascular and metabolic diseases risks: a cross-sectional, population-based study.

BMC cardiovascular disorders·2026
Same author

Cultivated Vegetation Shapes Diversity and Stability of Spontaneous Herbaceous Communities in Residential Green Spaces.

Ecology and evolution·2026
Same author

mTORC1-Dependent Regulation of the CCL24-CCR3 Axis Controls Granuloma Formation and Maintenance in Sarcoidosis.

Molecular and cellular biology·2026

Related Experiment Video

Updated: Jul 4, 2026

Protein Target Prediction and Validation of Small Molecule Compound
10:21

Protein Target Prediction and Validation of Small Molecule Compound

Published on: February 23, 2024

CoAff-DTI: Fine-grained drug-target interaction prediction using pre-trained language models and affinity-guided

Jia Peng1, Xiaoyu Liu1, Lei Wang2

  • 1College of Computer Science and Technology, Hengyang Normal University, Hengyang, Hunan, 421000, China.

Journal of Biomedical Informatics
|July 2, 2026
PubMed
Summary

CoAff-DTI enhances drug-target interaction (DTI) prediction by modeling localized biochemical features. This deep learning framework improves accuracy and interpretability in drug discovery by capturing fine-grained interactions between drugs and protein binding sites.

Keywords:
Deep learningDrug discoveryDrug–target interactionsPre-trained language models

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Related Experiment Videos

Last Updated: Jul 4, 2026

Protein Target Prediction and Validation of Small Molecule Compound
10:21

Protein Target Prediction and Validation of Small Molecule Compound

Published on: February 23, 2024

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Area of Science:

  • Computational chemistry
  • Bioinformatics
  • Drug discovery

Background:

  • Accurate drug-target interaction (DTI) prediction is crucial for efficient drug discovery.
  • Pre-trained language models (PLMs) excel at molecular and protein representations but struggle with fine-grained biochemical interactions.
  • Existing global embedding methods limit predictive accuracy and biological interpretability of DTIs.

Purpose of the Study:

  • To develop an advanced deep learning framework, CoAff-DTI, for enhanced multi-scale interaction modeling in DTI prediction.
  • To address the challenge of underrepresented localized interaction patterns in DTI prediction.
  • To improve both the accuracy and biological interpretability of DTI prediction models.

Main Methods:

  • CoAff-DTI employs a token-level decomposition strategy to generate pharmacophore- and residue-level representations from global embeddings.
  • An Affinity-Guided Cross-Attention (AGCA) module explicitly models fine-grained interactions between ligand substructures and protein residues.
  • An Affinity-Gating Fusion (AGF) module dynamically integrates cross-modal features for enhanced DTI prediction.

Main Results:

  • CoAff-DTI consistently outperformed state-of-the-art methods across multiple benchmark datasets.
  • Attention-based visualizations demonstrated improved model interpretability.
  • Learned attention patterns in CoAff-DTI effectively aligned with experimentally verified protein binding regions.

Conclusions:

  • CoAff-DTI offers a robust framework for accurate and interpretable DTI prediction.
  • The model's multi-scale interaction modeling capabilities advance computational drug discovery.
  • CoAff-DTI's ability to capture localized features represents a significant improvement over conventional global embedding approaches.